News
Treatment with retifanlimab plus carboplatin-paclitaxel statistically significantly reduced the risk of progression or death by 37% compared with placebo plus carboplatin-paclitaxel.
The following is a summary of “Oral semaglutide for the treatment of obesity: a retrospective real-world study,” published in ...
Whole Foods customers warned about E. coli contamination in organic ground beef. Check your freezer for these specific dates ...
Natalie Schnaitmann discusses the importance of self-advocacy and access to second opinions when symptoms are dismissed among ...
The Food and Drug Administration has approved Zoryve (roflumilast) topical foam, 0.3% for plaque psoriasis of the scalp and body.
1d
News-Medical.Net on MSNStudy reveals 15 hidden genetic risk factors for celiac diseaseBy Hugo Francisco de Souza The largest-ever genetic study uncovers 15 new genetic risk factors for celiac disease, opening ...
Learn how often do I give my cat Drontal worming tablets with our comprehensive guide. Get the facts on dosage and ...
The 52-year-old director of the medical department at the Beijing Children's Welfare Institute is fondly called "mom" by the ...
The U.S. Centers for Disease Control and Prevention (CDC) is warning of a Salmonella outbreak linked to several brands of ...
Among the 43 evaluable patients treated with sevabertinib, the confirmed objective response rate was 72.1%.
ZORYVE cream, 0.3%, is indicated for topical treatment of plaque psoriasis, including intertriginous areas, in adult and pediatric patients 6 years of age and older. ZORYVE cream, 0.15%, is indicated ...
Twenty-six people from 15 states have gotten sick from the same strain of Salmonella linked to whole cucumbers. Nine of these ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results